A new study published today (22 December 2023) in Nature Communications details that markers of brain injury are present in the blood many months after COVID-19 infection, despite inflammation blood tests being normal.
MoonLake’s PhII data on skin disease set it up against Cosentyx, UCB and others in IL-17 field
MoonLake Immunotherapeutics says it’s cleared the bar in a Phase II trial of its IL-17A and IL-17F inhibitor in hidradenitis suppurativa. In its 234-patient MIRA